ATERAterian, Inc.

Nasdaq aterian.io


$ 2.94 $ 0.04 (1.38 %)    

Thursday, 22-Aug-2024 14:56:16 EDT
QQQ $ 476.05 $ -8.12 (-1.68 %)
DIA $ 407.27 $ -3.17 (-0.77 %)
SPY $ 556.67 $ -5.73 (-1.02 %)
TLT $ 97.77 $ -0.44 (-0.45 %)
GLD $ 229.31 $ -0.96 (-0.42 %)
$ 2.97
$ 2.90
$ 2.90 x 100
$ 2.93 x 100
$ 2.90 - $ 3.02
$ 1.90 - $ 6.54
52,258
na
25.51M
$ 1.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-09-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-19-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 03-16-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-16-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-11-2021 03-31-2021 10-Q
15 03-16-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-30-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aterian-expects-q3-net-revenue-of-25m-27m-vs-26148m-consensus-sees-adj-ebitda-of-00m-06m

Third Quarter Outlook For the third quarter of 2024, Aterian Management believes that net revenue will be between $25.0 millio...

 aterian-q2-2024-gaap-eps-052-beats-064-estimate-sales-27984m-beat-23945m-estimate

Aterian (NASDAQ:ATER) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.64) by 18...

 aterian-boosts-q2-net-revenue-outlook-from-20m---23m-to-23m---26m-est-21633m

The Company today also announced an update to its previously stated Adjusted EBITDA loss to be in the range of ($1.0) million t...

 aterian-names-arturo-rodriguez-as-ceo-josh-feldman-as-cfo

Joe Risico has resigned as Co-CEO and from the Board of Directors and will consult the Company over a three month transition pe...

 alliance-global-partners-upgrades-aterian-to-buy

Alliance Global Partners analyst Brian Kinstlinger upgrades Aterian (NASDAQ:ATER) from Neutral to Buy.

 aterian-affirms-2h24-adjusted-ebitda-profitability-target-sees-q2-net-revenue-of-20m-23m-est-21656m

For the second quarter 2024, taking into account the current global environment and inflation, we believe that net revenue will...

 aterian-q1-2024-gaap-eps-076-beats-112-estimate-sales-20214m-beat-19445m-estimate

Aterian (NASDAQ:ATER) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of $(1.12) by 32...

 aterian-expects-q1-revenue-of-200m-210m-prior-180m-210m-vs-1945m-est

Aterian, Inc. (NASDAQ:ATER) ("Aterian" or the "Company") today announced updates to its previously announced ne...

 aterian-expands-reach-begins-selling-on-mercado-libre-marketplace-in-mexico

Aterian revealed partnership with Mercado Libre, tapping into Latin America's e-commerce boom. Aterian begins selling home ...

 why-cutera-shares-are-trading-lower-by-over-26-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...

 why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION